BIIB
Biogen Inc. · Healthcare · Drug Manufacturers - General
Momentum-inputs (vergelijkbare managers):
breedte van houders +12.5% ·
aandelenstroom +0.5% ·
netto nieuwe posities +11.1%
· formule
Brede accumulatie: stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | -1 | 75.75K | $11.04M | n/a | −3 |
| Q2 2026 | 159 | 0 | 117.81M | $25.44B | +6 | −7 |
| Q1 2026 | 163 | -1 | 110.78M | $20.30B | +4 | −6 |
| Q4 2025 | 163 | 0 | 123.15M | $21.67B | +2 | −1 |
| Q3 2025 | 24 | +1 | 81.72M | $11.44B | +1 | −1 |
| Q2 2025 | 21 | 0 | 78.50M | $9.86B | n/a | n/a |
| Q1 2025 | 18 | +2 | 41.87M | $5.73B | +3 | −1 |
| Q4 2024 | 16 | -1 | 41.64M | $6.37B | n/a | −1 |
| Q3 2024 | 16 | +2 | 32.39M | $6.28B | +2 | n/a |
| Q2 2024 | 14 | n/a | 30.72M | $7.12B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | PRIMECAP Management ✦ | 15.94M | -0.6% | $2.18B | 1.8% | ▼ Trim | 4 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (passief) | 7.40M | 0.0% | $1.01B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 4.67M | -5.2% | $639.38M | 0.1% | ▼ Trim | 4 | SEC ↗ ×5 |
| 4 | Geode Capital Management ✦ (passief) | 3.85M | +4.1% | $524.77M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (passief) | 2.15M | -7.4% | $294.67M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 1.59M | -1.5% | $216.97M | 0.3% | ▼ Trim | 4 | SEC ↗ ×2 |
| 7 | AQR Capital Management ✦ | 1.37M | +153.6% | $187.26M | 0.2% | ▲ Add | 4 | SEC ↗ ×7 |
| 8 | T. Rowe Price ✦ | 1.15M | -40.5% | $157.53M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 9 | Two Sigma Investments ✦ | 879.33K | +3.2% | $120.33M | 0.3% | ▲ Add | 4 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 804.51K | -32.5% | $110.09M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 541.76K | +252.6% | $74.13M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 12 | Millennium Management ✦ | 424.00K | -22.0% | $58.02M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 407.26K | Nieuw | $55.73M | 0.2% | New | 1 | SEC ↗ |
| 14 | Fisher Asset Management ✦ | 299.03K | +65.3% | $40.92M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Arrowstreet Capital ✦ | 214.78K | Nieuw | $29.39M | 0.0% | New | 1 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 99.23K | +10.7% | $13.58M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 17 | Adage Capital Partners ✦ | 70.77K | Nieuw | $9.68M | 0.0% | New | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 5.90K | -92.6% | $807,356 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Point72 Asset Management | $55.73M | 0.2% |
| Arrowstreet Capital | $29.39M | 0.0% |
| Adage Capital Partners | $9.68M | 0.0% |
Verlaten
| Bridgewater Associates | $10.71M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 995 houders, 132.27M aandelen, $23.30B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.